Electrical stimulation of the primary motor cortex has been used since 1991 to treat chronic neuropathic pain. Since its inception, motor cortex stimulation (MCS) treatment has had varied clinical outcomes. Until this point, there has not been a systematic study of the stimulation parameters that most effectively treat chronic pain, or of the mechanisms by which MCS relieves pain. Here, using a rodent model of central pain, we perform a systematic study of stimulation parameters used for MCS and investigate the mechanisms by which MCS reduces hyperalgesia. Specifically, we study the role of the inhibitory nucleus zona incerta (ZI) in mediating the analgesic effects of MCS. In animals with mechanical and thermal hyperalgesia, we find that stimulation at 50 lA, 50 Hz, and 300 ls square pulses for 30 minutes is sufficient to reverse mechanical and thermal hyperalgesia. We also find that stimulation of the ZI mimics the effects of MCS and that reversible inactivation of ZI blocks the effects of MCS. These findings suggest that the reduction of hyperalgesia may be due to MCS effects on ZI.
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Introduction
Central pain is defined as pain resulting from primary lesion or dysfunction in the central nervous system [34] . The pain is unrelenting, and refractory to pharmacologic treatments Stimulation of other brain structures has also been used for the treatment of neuropathic pain. These include the internal capsule [37], the periaqueductal gray-periventricular gray complex [25] , and the thalamus [38] . However, motor cortex stimulation (MCS) is more effective and more advantageous because of the low occurrence of complications [9], the lower propensity to cause seizures [2, 15] , and the ability to apply it noninvasively using repetitive transcranial magnetic stimulation [27] .
Human studies report mixed outcomes after MCS and success rates vary. MCS relieves pain in approximately 50% of patients [21, 31] , while studies involving only patients with CPS report success rates as high as 77% [60,61] (but see [14] ). The mixed success rates and the mixed outcomes after MCS are a reflection of the complexity and variability of neuropathic pain conditions. Adding to the variability of MCS efficacy is the lack of standardized surgical, stimulation, and treatment protocols [20] . In human studies, stimulation parameters vary (intensities: 1 to 8 V, frequencies: 15 to 130 Hz, pulse duration: 60-500 ls), as do stimulation protocols (MCS on range: 15 minutes-3 hours, MCS off: 2-24 hours; reviewed in [31]). Because of this variability, it is not clear which stimulus parameters are critical for MCS to be successful.
Pain relief occurs almost immediately after onset of MCS and persists after the stimulation has stopped. Like stimulation parameters, the duration of effect after cessation of stimulation (''post effect'') is rarely systematically examined, and reported values vary among studies. In some reports, these post effects were minimal and lasted for only 5-10 minutes [54, 55, 61] . In others, post effects varied from 45 minutes-2 hours [45], 3-5 hours [56] , and even up to 1-3 days [40, 41] . The variability in post effect duration is also a reflection of the various parameters used, various conditions predisposing for neuropathic pain, and different stimulation techniques.
Here, we take advantage of an animal model of central pain to systematically test a large parameter space of stimulus conditions. We determine the stimulus parameters that are effective in reducing hyperalgesia and study the mechanisms of increased inhibition in the thalamus following MCS.
